Concepedia

Apellis Pharmaceuticals (United States)

AP

Statistics

Publications

328

Citations

16.2K

Authors

19

Location

Waltham, United States

Apellis Pharmaceuticals (United States) is a company institution in Waltham, United States known for medicine, hematology, and immunology.

HomepageROR

Top concepts

Publications

328

Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration

David Liao, F Grossi, Delphine El Mehdi et al. · Ophthalmology · 2019 · 491 citations · Full text

Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

Jeffrey S. Heier, Eleonora M. Lad, Frank G. Holz et al. · The Lancet · 2023 · 372 citations

, , +4

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, Jeff Szer, Ilene C. Weitz et al. · New England Journal of Medicine · 2021 · 356 citations

<scp>C3</scp> inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab

Carlos de Castro, F Grossi, Ilene C. Weitz et al. · American Journal of Hematology · 2020 · 97 citations · Full text

The Effect of Pegcetacoplan Treatment on Photoreceptor Maintenance in Geographic Atrophy Monitored by Artificial Intelligence–Based OCT Analysis

Sophie Riedl, Wolf‐Dieter Vogl, Julia Mai et al. · Ophthalmology Retina · 2022 · 89 citations · Full text

1–5 of 328

Authors

19

  1. FG
    F Grossi

    Apellis Pharmaceuticals (United States), United States

    122 publications · 2.2K citations

    17

    h-index

  2. MA
    Mohammed Al-Adhami

    Apellis Pharmaceuticals (United States), United States

    73 publications · 931 citations

    15

    h-index

  3. PD
    Pascal Deschatelets

    Apellis Pharmaceuticals (United States), United States

    44 publications · 2.1K citations

    14

    h-index

  4. AM
    Alex McKeown

    Apellis Pharmaceuticals (United States), United States

    34 publications · 4.9K citations

    13

    h-index

  5. MY
    Michael Yeh

    Apellis Pharmaceuticals (United States), United States

    52 publications · 959 citations

    10

    h-index

1–5 of 19